Cargando…

Risk factor targeting for vaccine prioritization during the COVID-19 pandemic

A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Lloyd A. C., Shukla, Poojan, Rodríguez-Barraquer, Isabel, Shete, Priya B., León, Tomás M., Bibbins-Domingo, Kirsten, Rutherford, George W., Schechter, Robert, Lo, Nathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866501/
https://www.ncbi.nlm.nih.gov/pubmed/35197495
http://dx.doi.org/10.1038/s41598-022-06971-5
_version_ 1784655853629997056
author Chapman, Lloyd A. C.
Shukla, Poojan
Rodríguez-Barraquer, Isabel
Shete, Priya B.
León, Tomás M.
Bibbins-Domingo, Kirsten
Rutherford, George W.
Schechter, Robert
Lo, Nathan C.
author_facet Chapman, Lloyd A. C.
Shukla, Poojan
Rodríguez-Barraquer, Isabel
Shete, Priya B.
León, Tomás M.
Bibbins-Domingo, Kirsten
Rutherford, George W.
Schechter, Robert
Lo, Nathan C.
author_sort Chapman, Lloyd A. C.
collection PubMed
description A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular approach with stratification by demographics, risk factors, and location. We use this approach to compare the impact of different COVID-19 vaccine prioritization strategies on COVID-19 cases, deaths and disability-adjusted life years (DALYs) over the first 6 months of vaccine rollout, using California as a case example. We estimate the proportion of cases, deaths and DALYs averted relative to no vaccination for strategies prioritizing vaccination by a single risk factor and by multiple risk factors (e.g. age, location). When targeting by a single risk factor, we find that age-based targeting averts the most deaths (62% for 5 million individuals vaccinated) and DALYs (38%) and targeting essential workers averts the least deaths (31%) and DALYs (24%) over the first 6 months of rollout. However, targeting by two or more risk factors simultaneously averts up to 40% more DALYs. Our findings highlight the potential value of multiple-risk-factor targeting of vaccination against COVID-19 and other infectious diseases, but must be balanced with feasibility for policy.
format Online
Article
Text
id pubmed-8866501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88665012022-02-25 Risk factor targeting for vaccine prioritization during the COVID-19 pandemic Chapman, Lloyd A. C. Shukla, Poojan Rodríguez-Barraquer, Isabel Shete, Priya B. León, Tomás M. Bibbins-Domingo, Kirsten Rutherford, George W. Schechter, Robert Lo, Nathan C. Sci Rep Article A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular approach with stratification by demographics, risk factors, and location. We use this approach to compare the impact of different COVID-19 vaccine prioritization strategies on COVID-19 cases, deaths and disability-adjusted life years (DALYs) over the first 6 months of vaccine rollout, using California as a case example. We estimate the proportion of cases, deaths and DALYs averted relative to no vaccination for strategies prioritizing vaccination by a single risk factor and by multiple risk factors (e.g. age, location). When targeting by a single risk factor, we find that age-based targeting averts the most deaths (62% for 5 million individuals vaccinated) and DALYs (38%) and targeting essential workers averts the least deaths (31%) and DALYs (24%) over the first 6 months of rollout. However, targeting by two or more risk factors simultaneously averts up to 40% more DALYs. Our findings highlight the potential value of multiple-risk-factor targeting of vaccination against COVID-19 and other infectious diseases, but must be balanced with feasibility for policy. Nature Publishing Group UK 2022-02-23 /pmc/articles/PMC8866501/ /pubmed/35197495 http://dx.doi.org/10.1038/s41598-022-06971-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chapman, Lloyd A. C.
Shukla, Poojan
Rodríguez-Barraquer, Isabel
Shete, Priya B.
León, Tomás M.
Bibbins-Domingo, Kirsten
Rutherford, George W.
Schechter, Robert
Lo, Nathan C.
Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title_full Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title_fullStr Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title_full_unstemmed Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title_short Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
title_sort risk factor targeting for vaccine prioritization during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866501/
https://www.ncbi.nlm.nih.gov/pubmed/35197495
http://dx.doi.org/10.1038/s41598-022-06971-5
work_keys_str_mv AT chapmanlloydac riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT shuklapoojan riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT rodriguezbarraquerisabel riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT shetepriyab riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT leontomasm riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT bibbinsdomingokirsten riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT rutherfordgeorgew riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT schechterrobert riskfactortargetingforvaccineprioritizationduringthecovid19pandemic
AT lonathanc riskfactortargetingforvaccineprioritizationduringthecovid19pandemic